Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

AstraZeneca’s $1.7B AI Kidney Deal Exposes Hidden Validation Risks; Inside CSPC Partnership Shift in Pharma R&D Strategy

AstraZeneca has entered a $1.7 billion kidney disease drug discovery partnership with China-based CSPC Pharmaceutical Group, expanding their ongoing collaboration into renal therapeutics using siRNA-based drug discovery and AI-driven molecular design systems. The agreement, announced on July 3, 2026, aims
  • News
AstraZeneca’s $1.7B AI Kidney Deal Exposes Hidden Validation Risks; Inside CSPC Partnership Shift in Pharma R&D Strategy

EMA Exposes Clinical Trial Blind Spot; Women’s Data Gaps Could Delay Drug Approvals in 2026

The European Medicines Agency (EMA) has launched a major initiative to address long-standing gaps in women’s health representation within clinical trials and regulatory evidence frameworks. Announced on 2 July 2026, the initiative focuses on improving sex-based data integration in drug
  • News
EMA Exposes Clinical Trial Blind Spot; Women’s Data Gaps Could Delay Drug Approvals in 2026

FDA Finds Gaps in Genzyme’s Data Integrity Program; Warning Letter Cites Discarded Review Records

The FDA has issued a warning letter to Sanofi’s Genzyme manufacturing facility in Waterford, Ireland, after identifying significant weaknesses in Data Integrity and quality management during an inspection. The agency found deficiencies in laboratory record reviews, traceability, and deviation handling
  • News
FDA Finds Gaps in Genzyme's Data Integrity Program; Warning Letter Cites Discarded Review Records

Pharma Consultancy Services in 2026: GMP, Validation, Regulatory, and Quality Systems

Modern pharmaceutical companies rely on expert consulting to strengthen GMP compliance, validation, regulatory readiness, and quality systems. This guide explores the core consulting disciplines, practical selection criteria, and proven strategies that drive operational excellence throughout the pharmaceutical product lifecycle.
  • Blog, Quality Management System
Pharmaceutical consulting company supporting GMP consulting, Validation consulting, Regulatory Affairs consulting, and Pharmaceutical Quality Assurance across the product lifecycle.

US Reshoring Looks Promising; GMP Validation Could Be the Real Bottleneck

New analysis suggests that pharmaceutical tariffs alone may not achieve the reshoring goals many policymakers expect. According to legal and industry experts in the United States, the economics of generic drug manufacturing, combined with GMP compliance costs and validation requirements,
  • News
US Reshoring Looks Promising; GMP Validation Could Be the Real Bottleneck

Roche Launches AXELIOS 1; Could This Transform Genome Sequencing?

Roche has unveiled AXELIOS 1 Sequencing Platform, its next-generation single-molecule sequencing system powered by Sequencing by Expansion (SBX) technology. The platform delivers same-day whole-genome sequencing while combining high accuracy, flexible throughput, and near real-time analysis. The launch reflects the growing
  • News
Roche Launches AXELIOS 1; Could This Transform Genome Sequencing?

Contamination Control in 2026: Annex 1 Compliance, GMP Risks, and Inspection Findings

Modern sterile manufacturing relies on integrated Sterility Assurance systems aligned with Annex 1 expectations. By combining Environmental Monitoring, Aseptic Processing, and Quality Risk Management, pharmaceutical companies reduce Cleanroom Contamination risks, prevent Cross Contamination, and strengthen GMP inspection readiness.
  • Blog, Computerized System Validation
Pharmaceutical cleanroom visual showing Sterility Assurance workflows, Environmental Monitoring systems, Aseptic Processing operations, and Quality Risk Management framework supporting Annex 1 compliance and reducing Cleanroom Contamination and Cross Contamination risks.

FDA Approves Tregzi; Manufacturing Data Became the Real Approval Story

Orca Bio has received FDA approval for Tregzi, the first engineered regulatory T-cell therapy designed to reduce chronic GVHD following allogeneic stem cell transplantation in adults with blood cancers. While the approval marks a major clinical achievement, it also highlights
  • News
FDA Approves Tregzi; Manufacturing Data Became the Real Approval Story